Han, S.C.; Yeon, S.; Kim, H.; Park, S.
Intranasal Application of Foxp3 Introduced with Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticles (Foxp3 NPs) Attenuates Allergic Inflammation in a Mouse Model of Allergic Rhinitis. Pharmaceutics 2025, 17, 575.
https://doi.org/10.3390/pharmaceutics17050575
AMA Style
Han SC, Yeon S, Kim H, Park S.
Intranasal Application of Foxp3 Introduced with Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticles (Foxp3 NPs) Attenuates Allergic Inflammation in a Mouse Model of Allergic Rhinitis. Pharmaceutics. 2025; 17(5):575.
https://doi.org/10.3390/pharmaceutics17050575
Chicago/Turabian Style
Han, Seung Cheol, Sunhee Yeon, Hyejeen Kim, and Sookyoung Park.
2025. "Intranasal Application of Foxp3 Introduced with Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticles (Foxp3 NPs) Attenuates Allergic Inflammation in a Mouse Model of Allergic Rhinitis" Pharmaceutics 17, no. 5: 575.
https://doi.org/10.3390/pharmaceutics17050575
APA Style
Han, S. C., Yeon, S., Kim, H., & Park, S.
(2025). Intranasal Application of Foxp3 Introduced with Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticles (Foxp3 NPs) Attenuates Allergic Inflammation in a Mouse Model of Allergic Rhinitis. Pharmaceutics, 17(5), 575.
https://doi.org/10.3390/pharmaceutics17050575